secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001609550-23-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q4 preliminary revenue ~$137.7M (+76% YoY); FY22 ~$407.7M (+75%)
--------------------------------------------------------------------------------

- Q4 2022 preliminary revenue $137.5M-$137.9M, ~76% YoY increase.
- Full-year 2022 revenue $407.5M-$407.9M, ~75% increase over FY 2021.
- Activated 61 new U.S. implant centers in Q4 (total 905); added 16 sales territories (total 225).
- European revenue growth driven by Germany, Switzerland, and the Netherlands.
- Published inaugural Environmental, Social, and Governance (ESG) report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/0001609550-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/insp-20230109.htm
  HTML page:      https://secwatch.observer/filing/0001609550-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer